Breast cancer is the most frequently diagnosed cancer in women in the United States
About 1 in 8 women will develop breast cancer at some point in their lifetime. In any given year, roughly 300,000 new cases are diagnosed in the United States — that includes both invasive breast cancer and ductal carcinoma in situ (DCIS), a non-invasive form found in the milk ducts. The number has remained relatively stable over the past decade, though detection patterns have shifted as screening practices have changed.
Breast cancer also occurs in men, though much less often. About 1 in 833 men will develop it, accounting for roughly 2,800 new cases per year in the U.S. — less than 1% of all breast cancers diagnosed. The disease behaves similarly in men and women, but men are often diagnosed at a later stage because the disease is less expected and may be overlooked.
Key Takeaways
- Approximately 1 in 8 women in the United States will develop breast cancer in their lifetime, making it the most common cancer diagnosis in women.
- Breast cancer incidence varies significantly by age, race, and other factors — a 40-year-old woman has a different risk than a 70-year-old woman.
- Mortality rates have declined over the past 30 years despite stable or rising incidence, largely because of earlier detection and improved treatments.
- Most breast cancers are found in women over 50, but the disease can and does occur in younger women and in men.
How breast cancer rates differ by age
Age is the strongest predictor of breast cancer risk. A 30-year-old woman has roughly a 1 in 227 chance of developing breast cancer in the next 10 years. By age 50, that risk rises to about 1 in 42 over the next decade. By age 70, it reaches approximately 1 in 27 over 10 years. These numbers reflect cumulative exposure to hormones and other risk factors over time.
The median age at diagnosis is 63, meaning half of all breast cancers are found in women younger than that and half in women older. This matters because screening recommendations differ by age group. Women in their 40s may be offered screening but are not routinely recommended for it by all organizations. Women 50 to 74 are the focus of most screening programs, and women over 75 may continue screening if they are in good health and have been screened regularly.
Differences in breast cancer rates by race and ethnicity
Breast cancer incidence and outcomes vary across racial and ethnic groups in ways that reflect both biology and access to care. White women have the highest incidence of breast cancer overall, but Black women have higher mortality rates — they are more likely to die from the disease even when accounting for age. This gap has widened over the past 30 years and reflects differences in tumor biology, stage at diagnosis, and treatment access.
Hispanic women and Asian American women have lower incidence rates than white women, though incidence in Hispanic women has been rising. Native American women have the lowest incidence but face barriers to screening and treatment. These patterns are not fixed — they change as screening practices, healthcare access, and reproductive patterns shift within communities.
Why incidence has stayed relatively flat while survival has improved
The number of new breast cancer diagnoses has not increased dramatically over the past 15 years, but the number of women surviving breast cancer has grown substantially. This apparent contradiction reflects two separate trends: mammography screening finds cancers that might not have caused symptoms, which can inflate the count of diagnosed cases without necessarily changing how many women actually develop the disease. At the same time, treatments have improved — hormone therapies, targeted drugs, and immunotherapies have extended survival for many types of breast cancer.
Mortality from breast cancer has fallen by roughly 40% since the 1980s. This decline is steeper in younger women and in white women, which is why the racial gap in outcomes has become more visible. The decline accelerated in the 2000s as newer drugs became available, particularly for HER2-positive and hormone receptor-positive cancers.
What "lifetime risk" actually means
The 1 in 8 figure describes the probability that a woman born today will develop breast cancer at some point before age 90. It does not mean that 1 in 8 women will have breast cancer right now, or that a woman who reaches age 50 without breast cancer has a 1 in 8 chance going forward. The risk is cumulative and front-loaded toward older ages.
This number also assumes average risk. A woman with a family history of breast cancer, a BRCA1 or BRCA2 mutation, or other known risk factors has a substantially higher lifetime risk — sometimes 50% or more. Conversely, a woman with no family history and no other risk factors has a lower risk than the population average. The 1 in 8 figure is useful for understanding population-level disease burden, but individual risk varies widely.
How breast cancer rates compare to other cancers
Breast cancer is the most common cancer in women, followed by lung cancer and colorectal cancer. In men, prostate cancer is most common, followed by lung cancer and colorectal cancer. Breast cancer accounts for about 15% of all new cancer diagnoses in the United States and roughly 7% of cancer deaths — a lower percentage of deaths than of diagnoses, which reflects the fact that breast cancer survival rates are relatively good compared to many other cancers.
Lung cancer, by contrast, accounts for a smaller share of diagnoses but a much larger share of deaths because it is often found at a later stage and has lower survival rates overall. This difference illustrates why incidence and mortality are not the same thing — a common cancer with good treatment outcomes may cause fewer deaths than a rarer cancer caught late.
Geographic and international variation in breast cancer rates
Breast cancer is more common in developed countries than in developing countries, a pattern driven largely by screening, reproductive factors, and hormone replacement therapy use. In the United States, incidence varies by state and region, though the differences are modest — generally ranging from about 120 to 135 cases per 100,000 women per year depending on the state. Northeastern states tend to have slightly higher rates, partly because of older populations and higher screening rates.
Globally, breast cancer incidence is rising in countries that are industrializing, as women have fewer children, breastfeed for shorter periods, and use hormone-based contraception and hormone therapy — all factors that increase risk. In some high-income countries, incidence has plateaued or begun to decline as hormone therapy use has fallen and screening practices have stabilized.
Frequently Asked Questions
Is breast cancer becoming more common?
Incidence has been relatively stable for the past 15 years in the United States, though it rose modestly in the 1990s and 2000s. Rates are rising in some developing countries as reproductive patterns and healthcare access change. In the U.S., the stability masks shifts within age groups — incidence in younger women has risen slightly while rates in older women have declined.
Why do more women get breast cancer than men?
Women have far more breast tissue than men, and breast tissue is where the disease originates. Hormonal factors also play a role — estrogen and progesterone influence breast cell growth. Men can develop breast cancer, but it is rare because they have less breast tissue and different hormone levels. When men do develop it, the disease behaves similarly to breast cancer in women.
Does having a family history mean I will definitely get breast cancer?
No. A family history increases risk, but most women with a family history never develop breast cancer. If a close relative had breast cancer, your risk is higher than average, but it depends on how many relatives were affected, how young they were at diagnosis, and whether a genetic mutation runs in the family. A genetic counselor can help assess your individual risk.
Are breast cancer rates higher now than they were 50 years ago?
Incidence has increased since the 1970s, but much of that increase reflects better detection through mammography screening rather than a true rise in disease occurrence. Mortality has fallen sharply despite stable or rising incidence, which indicates that screening and treatment improvements have had a major impact on outcomes.
What percentage of breast cancers are found early?
About 63% of breast cancers are diagnosed at a localized stage, before the cancer has spread to lymph nodes or distant sites. This high percentage of early detection is one reason breast cancer survival rates are relatively good. However, early detection rates vary by race, age, and access to screening — Black women and younger women are more likely to be diagnosed at later stages.